Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Salvetti

Showing results (161-170 of 231) with videos related to

Pageof 24
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 9, 2016
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot studyMaria Chiara Buscarinu, Benedetta Cerasoli, Viviana Annibali, et al.
Frontiers in Immunology|December 28, 2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patientsIvan Arisi, Leonardo Malimpensa, Valeria Manzini, et al.
Cancers|July 12, 2025
Glioblastoma: Overview of Proteomic Investigations and Biobank Approaches for the Development of a Multidisciplinary Translational NetworkGiusy Ciuffreda, Sara Casati, Francesca Brambilla, et al.
Frontiers in Immunology|August 16, 2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosisTatiana Koudriavtseva, Svetlana Lorenzano, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MSRobert J Fox, Alan Thompson, David Baker, et al.
Plos One|February 27, 2025
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosisViola Costa, Kenda Aluan, Irene Schiavetti, et al.
Genes|October 3, 2020
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine TreatmentMario Stampanoni Bassi, Fabio Buttari, Ilaria Simonelli, et al.
Journal of Autoimmunity|May 4, 2019
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple SclerosisMartina Severa, Fabiana Rizzo, Sundararajan Srinivasan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 3, 2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)Eleonora Galosi, Rocco Costanzo, Francesca Forcina, et al.
Journal of Neurology|November 4, 2022
Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategiesLaura Fionda, Antonio Lauletta, Luca Leonardi, et al.
Pageof 24

Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 9, 2016
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot studyMaria Chiara Buscarinu, Benedetta Cerasoli, Viviana Annibali, et al.
Frontiers in Immunology|December 28, 2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patientsIvan Arisi, Leonardo Malimpensa, Valeria Manzini, et al.
Cancers|July 12, 2025
Glioblastoma: Overview of Proteomic Investigations and Biobank Approaches for the Development of a Multidisciplinary Translational NetworkGiusy Ciuffreda, Sara Casati, Francesca Brambilla, et al.
Frontiers in Immunology|August 16, 2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosisTatiana Koudriavtseva, Svetlana Lorenzano, Maria Cellerino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MSRobert J Fox, Alan Thompson, David Baker, et al.
Plos One|February 27, 2025
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosisViola Costa, Kenda Aluan, Irene Schiavetti, et al.
Genes|October 3, 2020
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine TreatmentMario Stampanoni Bassi, Fabio Buttari, Ilaria Simonelli, et al.
Journal of Autoimmunity|May 4, 2019
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple SclerosisMartina Severa, Fabiana Rizzo, Sundararajan Srinivasan, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 3, 2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)Eleonora Galosi, Rocco Costanzo, Francesca Forcina, et al.
Journal of Neurology|November 4, 2022
Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategiesLaura Fionda, Antonio Lauletta, Luca Leonardi, et al.
Pageof 24